X-Vax Technology
Jupiter
About X-Vax Technology
X-Vax Technology is a biotechnology company focused on the preclinical and clinical development of vaccines against pathogens that cause mucosal infections such as herpes, influenza, tuberculosis and HIV, affecting hundreds of millions of people around the globe. They believe that inducing antibodies that mediate the killing of infected cells will provoke an entirely new and effective immune response – so that they can finally beat these pathogens. The company was founded in 2015 and based in Jupiter, Florida.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $56.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2019)
- Website: x-vax.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/x-vax-technology-124014 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.